MYOS Corporation Receives Notice of Allowance of U.S. Patent Application for Proprietary Manufacturing Methods of Fortetropin - Patent will protect MYOS' intellectual property portfolio for Fortetropin through 2033 – - Key patent highlights the innovation underlying MYOS' novel myostatin inhibitor technology and...